Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[LutherTiggs]

Why change the retail price now?

STSI has clearly stated that plan is to emphasize pursuit of the prescription version(s) of Anatabloc as the most lucrative path. For now, at least you might as well keep the price high to reinforce its "worth". When/if enough consumer/market buzz is created around Abloc to make a big difference in retail potential, then you re-evaluate your options. But not until then. My guess is that STSI does want to keep retail alive and viable due to value of loyal customer base, commitments to GNC, and as a hedge against FDA approvals/pharma partnership potential going smoothly.